Cathay Capital Invests In French Pharma Firm Cenexi


Sino-French private equity firm Cathay Capital Private Equity has invested in French pharmaceutical development and manufacturer the Cenexi Group, according to a company announcement.

Deal terms were not disclosed.

Paris-based Cenexi Group is previously a subsidiary of the Roche Group, and has the largest production site for sterile ampoules in Europe.

The company became an independent company in 2008, and acquired two new production sites in Osny in France and in Braine l’Alleud in Belgium.

Cathay Capital plans to help expand the company’s businesses internationally.

 

RELATED NEWS